New pathways in drug discovery for alzheimer’s disease
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 6 (5) , 372-378
- https://doi.org/10.1007/s11910-996-0017-8
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyPublished by Elsevier ,2006
- The Role of Biomarkers in Clinical Trials for Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2006
- Exacerbation of Cerebral Amyloid Angiopathy-Associated Microhemorrhage in Amyloid Precursor Protein Transgenic Mice by Immunotherapy Is Dependent on Antibody Recognition of Deposited Forms of Amyloid βJournal of Neuroscience, 2005
- Cerebral Hemorrhage After Passive Anti-Aβ ImmunotherapyScience, 2002
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MicePublished by Elsevier ,2001
- Amyloid-β Interactions with Chondroitin Sulfate-derived Monosaccharides and DisaccharidesJournal of Biological Chemistry, 2001
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- Isolation and quantification of soluble Alzheimer's β-peptide from biological fluidsNature, 1992
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976